BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 963910)

  • 1. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple one-step hemolytic assay for C2 with C2-deficient human serum.
    Ngan BY; Gelfand EW; Minta JO
    J Immunol; 1977 Mar; 118(3):736-41. PubMed ID: 321681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
    J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Coagulation studies in C4-deficient guinea pigs.
    Dodds WJ; Raymond SL; Moynihan AC; Pickering RJ; Amiraian K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):602. PubMed ID: 1198523
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rapid kinetic assay for the function of the classical pathway of the complement system and for C2 and C4.
    Kolde HJ; Deubel R
    J Clin Lab Immunol; 1986 Dec; 21(4):201-7. PubMed ID: 3560196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary non-allergic angioneurotic edema and the complement system (author's transl)].
    Exss R; Britz I
    Klin Padiatr; 1976 Mar; 188(2):194-200. PubMed ID: 944358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS; Glovsky M
    Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
    Nydegger UE; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second component of complement (C2) as an index of hereditary angioneurotic edema.
    Sobel AT; Moisy M; Belghiti D; Gabay Y; Lagrue G
    J Clin Lab Immunol; 1978 Nov; 1(3):179-81. PubMed ID: 756467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement in rheumatoid articular inflammation].
    Boloşiu HD; Duţu A; Duţu D; Duma V; Gligore V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(6):469-74. PubMed ID: 3842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.